THE SAGE GROUP Announces that Mary L. Yost, President, Will Make a Presentation on Peripheral Artery Disease (PAD) Prevalence and Economics at the NEW CARDIOVASCULAR HORIZONS Conference
ATLANTA, May 10, 2011 (BUSINESS WIRE)—THE SAGE GROUP announced today that Mary L. Yost will present a lecture titled, “What is the True Prevalence of PAD and What is its’ Overall Economic Impact” at the twelfth annual New Cardiovascular Horizons (NCVH) conference held June 1-4, 2011 at The Roosevelt Waldorf-Astoria in New Orleans, Louisiana. Ms. Yost will be speaking on Wednesday, June 1st at the General Session, “Assessing the Incidence, Cardiovascular and Economic Ramifications of PAD” in the Crescent City Ballroom.
About NEW CARDIOVASCULAR HORIZONS
NCVH is the 4th largest cardiovascular conference in the nation and the largest medical meeting to focus on PAD (peripheral artery disease) and peripheral interventions with a special emphasis on critical limb ischemia (CLI). A unique "head-to-toe" meeting, NCVH brings together a multidisciplinary team of health professionals to focus on total cardiovascular care in patients with PAD and CLI.
The True Prevalence of PAD and the Economic Impact
Ms. Yost’s presentation will analyze and compare the methods and results of four unique estimates of U.S. PAD prevalence. This discussion will include an overview of the key variables that affect prevalence, as well as the impact of specific PAD definitions on disease prevalence.
Assessment of the 2010 economic burden includes the total annual costs of inpatient and outpatient treatments and medications, as well as hospital costs related to PAD-specific treatments, cardiovascular disease events and therapies and all-cause hospitalizations. Costs are also analyzed for asymptomatic patients and those with polyvascular disease. Finally, the economic burden of PAD is compared with that of coronary artery disease and cerebrovascular disease.
Following the lecture copies of the slides will be available on request; in addition the slides will be posted on THE SAGE GROUP website in the Slides section.
PAD, also known as peripheral vascular disease (PVD), is characterized by a reduction of blood flow to the lower limbs due to atherosclerosis. PAD is also sometimes known as peripheral arterial obstructive disease (PAOD).
In the severe stages of PAD (critical limb ischemia or CLI) blood flow is so inadequate that ulcerations and gangrene occur. Once PAD has progressed to CLI, the risks of limb loss and mortality increase.
THE SAGE GROUP, a research and consulting company, specializes in atherosclerotic disease in the lower limbs, specifically PAD (Peripheral Artery Disease), CLI (Critical Limb Ischemia) and ALI (Acute Limb Ischemia) as well as PAD and diabetic foot ulcers (DFU).
For additional information visit www.thesagegroup.us.
SOURCE: THE SAGE GROUP
THE SAGE GROUP, Atlanta
Harrington Witherspoon, 404/816-0746